共 50 条
- [1] Randomized Phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancerCANCER RESEARCH, 2022, 82 (12)Hanna, DianaJameson, Gayle S.Rasco, Drew W.Alistar, AngelaFrank, Richard C.El-Khoueiry, Anthony B.Wiedmeier, Julia E.Roberts, CarolineFell, BrandonHallberg, SarahRoe, DeniseCridebring, DerekRabinowitz, JoshuaGately, Stephen ThomasVon Hoff, Daniel D.
- [2] Randomized phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancerJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)Hanna, Diana L.Jameson, Gayle S.Rasco, Drew W.Alistar, Angela TatianaFrank, Richard C.El-Khoueiry, Anthony B.Wiedmeier, JuliaRoberts, CarolineFell, BrandonHallberg, SarahRoe, DeniseCridebring, DerekRabinowitz, Joshua D.Gately, StephenVon Hoff, Daniel D.
- [3] Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial StudyNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2020, 72 (04): : 627 - 634Khodabakhshi, AdelehAkbari, Mohammad EsmaeilMirzaei, Hamid RezaMehrad-Majd, HassanKalamian, MiriamDavoodi, Sayed Hossein
- [4] Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation TrialJOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 412 - 419Smith, David C.Smith, Matthew R.Sweeney, ChristopherElfiky, Aymen A.Logothetis, ChristopherCorn, Paul G.Vogelzang, Nicholas J.Small, Eric J.Harzstark, Andrea L.Gordon, Michael S.Vaishampayan, Ulka N.Haas, Naomi B.Spira, Alexander I.Lara, Primo N., Jr.Lin, Chia-ChiSrinivas, SandySella, AvishaySchoeffski, PatrickScheffold, ChristianWeitzman, Aaron L.Hussain, Maha
- [5] Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II TrialANTICANCER RESEARCH, 2022, 42 (05) : 2683 - 2687Chin, KeishoTakahari, DaisukeKawabata, RyoheiHosaka, HisashiSaitou, S. O.Shiraishi, TakeshiYabusaki, HiroshiGoto, MasahiroNakamura, MasatoImamura, HiroshiShindo, YoshiakiNagashima, FumioIchikawa, WataruSaotome, TakashiYamamoto, WataruIshizuka, NaokiYamaguchi, Kensei
- [6] Final analysis of a multicenter, randomized phase II trial comparing three different chemoradiotherapy regimens in the treatment of patients with locally advanced, nonmetastatic pancreatic cancerJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Wilkowski, R.Boeck, S.Ostermaier, S.Sauer, R.Herbst, M.Fietkau, R.Flentje, M.Bruns, C. J.Rau, H. G.Heinemann, V.
- [7] A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancerInvestigational New Drugs, 2013, 31 : 85 - 91Sil KordesDick J. RichelHeinz-Josef KlümpenMariëtte J. WetermanArnoldus J. W. M. StevensJohanna W. Wilmink
- [8] A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancerINVESTIGATIONAL NEW DRUGS, 2013, 31 (01) : 85 - 91Kordes, SilRichel, Dick J.Klumpen, Heinz-JosefWeterman, Mariette J.Stevens, Arnoldus J. W. M.Wilmink, Johanna W.
- [9] Comparison of two different neoadjuvant chemoradiatiotherapy regimens for locally advanced rectal cancer: Results of a phase II, multicenter, randomized trial.JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Zhu, JiGuan, YunYan, SenxiangXu, YeLi, XinxiangCai, SanjunZhang, Zhen
- [10] A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancerJOURNAL OF THORACIC ONCOLOGY, 2006, 1 (01) : 19 - 24Masters, Gregory A.Argiris, Athanassios E.Hahn, Elizabeth A.Beck, J. ThaddeusRausch, P. GregoryYe, ZhishenMonberg, Matthew J.Bloss, Leslie P.Curiel, Rafael E.Obasaju, Coleman K.